Heart failure & cardiomyopathiesRandomised controlled trial
Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure
- Randomised controlled trial
Authors' conclusion
Three digital interventions showed no independent effect on QoL as assessed by the KCCQ OSS. However, participants randomized to the Noom technology demonstrated improved KCCQ TSS and CSS relative to usual care.
Study context
- Population
- Patients with heart failure (HF)151 (83%) completed 90-day surveys
- Participants
- 182 patients
- Comparison
- Digital health technologies vs usual care
- Primary endpoint
- Change in Quality of Life (QoL) by KCCQ Overall Summary Score (OSS)
- Follow-up
- 90 days
Primary result
As reported in the abstract
KCCQ OSS change
- No group had any significant change in Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score (OSS) or improvement relative to usual care
Further findings
Median change, points
| Outcome | Usual care | Bodyport | Conversa | Noom | P value |
|---|---|---|---|---|---|
| KCCQ Total Symptom Score (TSS) change · 90 days | −1 (IQR −13.5 to +7.8) | Not reported in the abstract | Not reported in the abstract | +4.2 (IQR −1 to +16.7) | P = 0.006 |
| KCCQ Clinical Summary Score (CSS) change · 90 days | −3.1 (IQR −10.2 to +3) | Not reported in the abstract | Not reported in the abstract | +2.8 (IQR −1 to +14.6) | P = 0.002 |
Original publication
Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure. JACC Heart Fail. Published 8 November 2023. doi:10.1016/j.jchf.2023.09.022
Summarised from the published abstract; every number is checked against it